Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2019 Aug 29;14(8):e0219337. doi: 10.1371/journal.pone.0219337

Exploring the role of the various methionine residues in the Escherichia coli CusB adapter protein

Aviv Meir 1, Gulshan Walke 1, Fabian Schwerdtfeger 1,2, Lada Gevorkyan Airapetov 1, Sharon Ruthstein 1,*
Editor: Dariush Hinderberger3
PMCID: PMC6715271  PMID: 31465444

Abstract

The dissemination of resistant pathogenic microbes has become one of the most challenging problems that modern medicine has faced. Developing novel drugs based on new molecular targets that previously were not targeted, is therefore the highest priority in antibiotics research. One approach that has been recently suggested is to inhibit copper transporters in prokaryotic systems. Copper is required for many biological pathways, but sometimes it can harm the cell. Pathogenic systems have a highly sophisticated copper-regulation network; therefore, a better understanding of how this network operates at the molecular level should assist in developing the next generation of antibiotics. The CusB protein is part of the CusCBA periplasmic Cu(I) efflux system in Gram-negative bacteria, and was recently reported to play a key role in the functioning of the whole CusCBA system, in which conformational changes as well as the assembly/disassembly process control the opening of the transporter. More knowledge of the underlying mechanism is needed to attain a full understanding of CusB functioning, which is associated with targeting specific and crucial residues in CusB. Here, we combine in-vitro structural measurements, which use EPR spectroscopy and UV-Vis measurements, with cell experiments to explore the role of the various methionine residues in CusB. We targeted two methionine residues (M227 and M241) that are essential for the proper functioning of CusB.

Introduction

Copper is an essential nutrient for aerobic organisms; its ability to exchange electrons as it cycles between cuprous and cupric states has been harnessed by enzymes that catalyze a wide variety of biochemical processes [1, 2]. However, this redox activity also confers copper with toxic properties when it is present in the free ionic form: free copper can participate in Fenton-like chemical reactions to generate the highly toxic hydroxyl radical from hydrogen peroxide and superoxide [35]. Owing to its toxicity, copper has been known as an antimicrobial agent for thousands of years [6]. It is therefore not surprising that microbes have developed tightly regulated mechanisms for copper transport and intracellular distribution, to maintain negligible changes (subfemtomolar concentrations) in their intracellular levels [79]. Selective inhibition of the copper efflux in microbes is expected to raise their copper levels, accelerate the Fenton reaction, and augment the production of free radicals. Ultimately, this chain of events kills the microbes.

Four different mechanisms regulate cellular Cu(I) in prokaryotic systems [10]: (i) the cytoplasmic CueR- metal sensor initiates the transcription process of CueO and CopA associated with Cu(I) coordination [11]; (ii) CopA uses the energy provided by ATP hydrolysis to drive the efflux of Cu(I) from the cytoplasm to the periplasm [12]; (iii) CusF, a metallochaperone, transfers Cu(I) from CopA to the CusCBA efflux system, which pumps Cu(I) from the periplasm to the extracellular region [13]; and (iv) CueO oxidizes Cu(I) to its less toxic oxidation state, Cu(II) [14]. Although homologs of CopA and CueO also exist in the human cells ATP7b and SOD, respectively, the CusCFBA and CueR systems are unique to prokaryotic systems. Thus, targeting the latter two copper transport systems with antibiotics might be very beneficial in terms of freedom from an antibiotic effect on human copper-transport systems. CueR is a metal sensor that senses the Cu(I) ion with high affinity and induces a transcription process [11, 15]. Metal sensors such as CueR exist in all microbes, but their structure and functionality vary among microbe types. In contrast, Cus efflux systems are found in many pathogenic microbes such as Legionella, Salmonella, Klebsiella, Pseudomonas, and many other Gram-negative bacteria. The sequence identity among all species is about 30%, and their structures and functions should be similar in all microbes.

The Cus complex comprises an inner membrane proton-substrate carrier (CusA) and an outer membrane protein (CusC). The inner and the outer membrane proteins are connected by a linker protein, CusB, in the periplasm, which is composed of CusA:CusB:CusC in a oligomerization ratio of 3:6:3 [16]. Owing to the large size of the system, the structure of the entire complex has not been elucidated; however, the crystal structures of the individual components (CusC, CusA, and CusB) and the CusBA complex have been determined [1719]. Padilla-Benavides et al. [20] have successfully demonstrated a specific interaction between the CopA transporter extracellular domain and CusF. Based on X-ray absorption spectroscopy, Chacón et al. [21] suggested that the CusB-CusF interaction functions as a switch for the entire Cus efflux system and facilitates the transfer of copper to the CusA component. Taken together, these findings indicate that in the periplasm, Cu(I) is transferred from CopA to CusF and then to the CusCBA complex through direct and specific interaction (Fig 1A). The crystal structure of E. coli CusB indicates that the protein is folded into an elongated narrow structure that comprises four domains with a flexible hinge between domains 2 and 3 of the protein [18]. Recently, we used electron paramagnetic resonance (EPR) spectroscopy-based nanometer distance measurements to show that CusB undergoes major structural changes associated with Cu(I) binding [22]; this results in two structures for the CusB dimer in solution: apo-CusB and holo-CusB (Fig 1B). The EPR data suggests a more compact structure upon Cu(I) binding, in agreement with the gel filtration chromatography experiments [23]. Moreover, Chen et al. showed that under copper stress, CusB changes its conformation and shifts the equilibrium from a disassembled CusCBA complex to an assembled one. Methionine residues in the CusB play a critical part in Cu(I) binding [24]. Bagai et al. revealed that four out of ten methionine residues (M49, M64, M66, and M311) in CusB are conserved [23]. Moreover, the crystal structure suggests that there are two methionine residues ((i) M190, domain 4, and (ii) M324, domain 1), which are not conserved, yet take part in Cu(I) binding [18]. The most studied region in CusB is the N-terminal domain (CusB_NT), which comprises 60 amino acids (residues 28–88) that were shown to interact directly with CusF [2527]. Studies on CusB knockout (ΔCusB) and CusBΔNT have revealed a Cu(I)-sensitive phenotype in cells and indicated that M64 and M66 of CusB_NT are important residues, both for Cu(I) coordination to CusB_NT as well as for its interaction with CusF, whereas M49 of CusB_NT is important for interacting with CusF [21, 2628]. Coupled with various constructs of ΔCusB, the McEvoy group found that CusB_NT is not fully functional by itself without the remaining part of the protein, and ruled out the idea that CusB acts only as a metal chelator [26]. They found that it is also involved in conformational changes resulting in a more compact form [23]. To date, Cu(I) binding sites in domain 2 and domain 3 of the CusB have not been reported. Since this region was found to undergo structural changes upon Cu(I) binding, we suspect that there may be additional Cu(I) sites that have not been targeted yet.

Fig 1. The CusCBA efflux system.

Fig 1

A. A schematic view of the CusCFBA periplasmatic efflux system. Cu(I) is transferred from the CusF metallochaperone to the N-terminal domain of CusB (CusB_NT) and out of the cell through CusB and CusC proteins by an unknown transfer mechanism. B. The CusB dimer structural models for apo-CusB (gray protein) and holo-CusB (blue colors) based on EPR constraints. C. The positions of the methionine residues (red colors) in the crystal structure of CusB monomer (PDB 3H94); residues 1–88 are missing from the crystal structure.

In the present study, we use a combination of in-vitro spectroscopic measurements and cell experiments to study the significance of each single methionine residue in CusB and its effect on cell survival. We demonstrate that two additional methionine residues of CusB, namely M227 (Domain 3), and M241 (Domain 2) (Fig 1C), are essential for cell growth and viability. Pulsed EPR spectroscopy confirms that the conformational changes in CusB, which were associated with Cu(I) binding, depend on these Met residues. This study emphasizes the role of domains 2 and 3 of CusB in the functioning of CusCBA transporter and regulation of in-cell copper concentration.

Results and discussion

Copper stress in CusB mutants during cell growth

The present study aimed to elucidate the various Cu(I) binding sites in CusB; we hypothesized that deletion of single methionine (Met) residues in CusB, which possibly play a role either in Cu(I) coordination [18, 2527] in the Cus channel assembly process, or in the transfer mechanism, may also affect cell viability upon Cu(I) stress. Ten Met residues exist in CusB; in order to determine which of them are essential for cell growth, each time one methionine residue was mutated to isoleucine. Initially, we knocked out CusB (ΔCusB) in the native E. coli cells and then transformed either WT or a mutated gene into the knocked out cells. The protein expression level was identical for all clones; therefore, we could compare the growth rates of the various mutants (S1 Fig). We used Cu(II) in the cell experiments because it can penetrate into the cell and is reduced to Cu(I) (S2 and S3 Figs). However, our conditions are not fully anaerobic; therefore, we also repeated the experiments in the presence of Cu(I), and the results were found to be similar (S4 and S5 Figs). This indicates that Cu(II) was reduced to Cu(I). The various clones were grown in M9 medium for 16 hr and their cell growth was compared in the absence and presence of Cu(II) in the medium. Growth rate values after 14 hr of cell growth for various CusB clones are presented in Fig 2.

Fig 2.

Fig 2

Cell growth rates for various CusB clones in the absence (black) and presence (gray) of 3 μM Cu(II) after 14 hr.

The ability of wild-type (WT) CusB to grow under Cu(II) stress was found to be 3 ± 0.4% less than in the absence of Cu(II) after 14 hr of growth (Fig 2). We also monitored the cell growth of each single mutation (Fig 2). All mutants grew less well than WT-CusB even before adding Cu(II) to the growth solution, due to the slight effect of the minimal copper concentration naturally present in the M9 bacterial growth medium (0.5 μM), and the significance of the methionine residues in CusB for preserving copper homeostasis. However, the cell growth experiments succeeded in targeting three Met residues that mostly affect the E. coli cell growth after 14 hr under Cu(II) stress: CusB_M64I –a reduction of 30 ± 3%; CusB_M241I –a reduction of 25 ± 4%, and CusB M227I –a reduction of 18 ± 3%. CusB_M398I resulted in a reduction of 7 ± 2% after 14 hr with 3 μM Cu(II), which was the largest reduction among the remaining clones (Fig 2). All other mutants affected cell growth by less than 5%. M11I shows the lowest effect on the growth rate as expected, since it is located in CusB signal (residues 1–28) peptide which is cleaved upon maturation, suggesting that M11I does not affect this cleavage process. Interestingly, in comparison with previous results, smaller reductions in growth rate were observed for the conserved methionine residues and for the M190 and M324 residues, which were suggested to play a role in Cu(I) binding by crystallography [18, 25, 26]. In addition, previous in-vitro ITC measurements were not able to detect the functionality of M227 and M241 residues [23]. Based on the cell experiments, we decided to focus on the four methionine residues which showed the largest effect on the growth rate, and may therefore form additional Cu(I) sites that were not identified earlier.

Targeting conformational changes in CusB mutants by DEER measurements

Over the last decade, double electron-electron resonance (DEER) spectroscopy, coupled with site-directed spin labeling (SDSL), has been found to be an excellent means of obtaining structural and dynamic information on complex systems [2936]. Hubbell et al. were the first to introduce the SDSL methodology in which they attached nitroxide spin labels to cysteine residues at selected positions within the protein [37, 38]; the most commonly used nitroxide spin label is the 1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl methanethiosulfonate spin label (MTSSL). The DEER technique, also called pulsed electron double resonance (PELDOR), is a pulsed electron paramagnetic resonance (EPR) technique used to measure dipolar interactions between two or more electron spins. Thus, it can provide nanometer-scale interspin distance information in the range of 1.5–8.0 nm. By using DEER and SDSL, we recently succeeded in targeting conformational changes in WT-CusB associated with Cu(I) binding [22]. We showed that CusB assumed a more compact structure (Fig 1B) upon Cu(I) binding, whereas most of the structural changes occurred in CusB domains 2 and 3. In order to explore the effect of methionine mutations on CusB conformation, we spin-labeled the protein at two sites: one at A236C (domain 3) and the second at A248C (domain 2). The DEER time domain signals are presented in Fig 3A and the corresponding distance distribution functions are in Fig 3B. Because CusB was found to be a dimer in solution [22], the distance distribution consists of all distances derived from the four spin-labels attached to the CusB dimer (Fig 3C). For WT-CusB, distance distributions of 2.5 ± 0.5 nm for the apo-state and 2.8 ± 0.3 nm for the holo-state (CusB+Cu(I)) were detected (Fig 3B). To compare the DEER data with the structure of CusB, we used the MMM software (2015 version) [39]. The software requires an entry PDB file, and the residues where the spin-labels are attached to the protein. This method describes spin labels by a set of alternative conformations or rotamers, which can be attached without serious clashes with atoms of other residues or cofactors. The rotamer library is derived from molecular dynamic simulation with a total length of 100 ns at a temperature of 175K, which is an estimate of the glass transition of a protein sample. Here we used the two structures of apo-CusB and holo-CusB, which were previously constructed based on various DEER constraints (Fig 1B) as an input PDB files for the MMM software [22]. The dashed black-line distribution in Fig 3B denotes the distance distribution obtained from MMM. The apo-state exhibits a broad distance distribution that is consistent with the calculated model structure of CusB, whereas in the holo-state the structure is more compact and rigid, which results in a much narrower distance distribution [22]. The orientation of the spin-labels in the two structures are presented in S6 Fig. DEER also confirmed that when one specific methionine residue among M64, M227, and M241 was mutated, structural changes in CusB protein associated with Cu(I) binding were affected. For simplicity, we used a linear composition of the apo-WT-CusB distance distribution with the holo-WT-CusB distance distribution (S6 Fig). Although the effect of each mutation on conformational changes may not be a simple two-step model between the apo- and holo-states, this approach can still provide us with an overview on how much each mutation disturbs the conformation and function of the CusB protein. In the case of CusB_M64I + Cu(I), the distance distribution is very similar to the apo WT-CusB distance distribution, suggesting that Cu(I) did not affect the conformation of CusB in the presence of M64I mutation. In contrast, for holo CusB_M398I, the distribution is slightly broader than the holo WT-CusB. However, the best fit was still obtained with 100% holo WT-CusB distance distribution, indicating that M398I did not affect the conformational changes of CusB upon Cu(I) binding. For CusB_M227I and CusB_M241I, the best fit was obtained with convolutions of 50% and 90%, respectively, of the apo-WT-CusB distance distribution with the holo-WT-CusB distance distribution. This suggests that both mutations affect the conformational changes of CusB in the presence of Cu(I), while M241I has a larger effect on conformation of CusB than the M227I mutation. The DEER agrees well with the cell experiments. When M398I, which hardly affects the cell growth, was mutated, the conformational changes induced by the Cu(I) binding was almost not affected. In contrast, M64I largely affected the cell growth consistent with the DEER data that showed that CusB did not assume any conformational changes upon Cu(I) binding. This suggests that Cu(I) needs to first bind to the N-terminal domain of CusB and then to transfer to the next site. Mutations in M227 and M241 which showed partial effects on cell growth, disturb the conformational changes induced by CusB in the presence of Cu(I), but do not completely inhibit it as does the M64I mutation. The DEER data indicate that mutations of M64, M227, and M241 affect both the cell growth and conformational changes in CusB and that the conformational changes presented in Fig 1B are essential for the protein to function.

Fig 3. Distance distribution measurements (DEER) on CusB mutants.

Fig 3

A. DEER time domain signals (solid lines) and fits (dashed lines) based on Tikhonov regularization for apo-CusB and CusB + Cu(I) (at a Cu(I):CusB ratio of 3:1) and various CusB + Cu(I) mutants spin labeled at the A236C and A248C positions. B. Corresponding distance distribution functions. The dashed lines represent calculated distribution functions obtained for the apo-CusB and CusB + Cu(I) structure models. C. The positions of the spin labels in WT-CusB (A236C,A248C). The red dotted lines denote the six distances targeted here under the broad distance distribution.

Cu(I) affinity to CusB

The affinity of CusB proteins for Cu(I) binding was evaluated by using the spectrophotometric competition assay with bicinchoninic acid (BCA) as a ligand (Eq 1).

P+ML2MP+2L (1)

where P corresponds to CusB protein, M corresponds to Cu(I), and L corresponds to BCA.

Cu(I) ions binding BCA with a stoichiometric ratio of 1:2. Cu(I)-(BCA)2 show a characteristic high absorption at 562 nm. The binding affinity of proteins for Cu(I) can be calculated by monitoring the change in the absorption peak intensity of the Cu(I)-(BCA)2 complex at 562 nm, which is associated with protein titration [40, 41].

When the solution of the Cu(I)-(BCA)2 complex was titrated with CusB mutants, the CusB mutant competed for Cu(I) with BCA, thereby decreasing the concentration of Cu(I)-(BCA)2, which lowered the absorption peak intensity at 562 nm. Fig 4A and 4B show the absorption spectra recorded for the titration of Cu(I)-(BCA)2 with WT-CusB and CusB_M64I, respectively. The decrease in the absorption peak at 562 nm suggests that both WT-CusB and CusB_M64I may compete for Cu(I) with BCA. However, the affinity of CusB_M64I for Cu(I) is weaker than that of WT-CusB. Fig 4C presents changes in the absorption peak at 562 nm for various CusB mutants, as affected by Cu(I) concentration; it shows that WT-CusB binds Cu(I) with the highest affinity, whereas CusB_M64I has the lowest affinity for Cu(I).

Fig 4. Cu(I) affinity to CusB mutants.

Fig 4

Absorption spectra for Cu(I)-(BCA)2 titrated with A. WT-CusB, B.CusB_M64I, C. Absorbance at 562 nm of Cu(I)-(BCA)2 titrated with various CusB mutants.

The KD value for CusB-Cu(I) complexes was calculated according to a procedure developed by Xiao et al. [42]:

KDβ2=([CusB]total[CusBCu(I)])1{([BCA]total[BCA2Cu(I)])2}2[BCA2Cu(I)], (2)

where β2 is a constant for [BCA2-Cu(I)] formation [43], [BCA]total and [CusB]total are the concentrations used in the experiment, and [CusB-Cu(I)] and [BCA2-Cu(I)] were calculated based on the absorbance changes that were normalized to the values without CusB (Table A in S1 File):

[CuBCu(I)]=[Cu(I)]/(1abs562abs562,0) (3)
[BCA2Cu(I)]=[Cu(I)](abs562abs562,0) (4)

To derive the KD values, we used β2 = 1017.2 M-2 [40, 41]. The calculated KD values are listed in Table 1.

Table 1. Calculated KD values for CusB mutants.

KD [M];×10−14
WT-CusB 8.7 ± 0.3
CusB_M64I 27.8 ± 0.4
CusB_M227I 15.6 ± 1.5
CusB_M241I 19.1 ± 0.4
CusB_M398I 8.9 ± 0.1

An increase in the KD value indicates that the Cu(I) binding to CusB is weaker. The lowest KD value was observed for WT-CusB; the highest value was for CusB_M64I; however, CusB_M241I had a slightly higher KD value than that of CusB_M227I. This result is very consistent with the DEER measurement, which showed more significant inhibition of the conformational changes in CusB associated with Cu(I) binding for CusB_M241I than for CusB_M227I.

Cell viability decrease due to Cu(II) stress on CusB mutants during growth

We conducted live/dead fluorescence cell imaging experiments to determine whether point mutations may lead to cell death or only to a reduction in E. coli cell growth (Fig 5A, in which red and green dots denote dead and live cells, respectively). At the late lag phase, some dead cells were observed in the M9 medium, even for the WT-CusB clone, because M9 was a poor medium. Note that the late lag phase is different for all mutants; it is determined by the growth rate (S3 Fig). A comparison of cell images of the WT clone with those of the CusB_M64I clone at the late lag phase (Fig 5B) indicates a 62 ± 7% increase in the dead cell count before incorporating Cu(II) into the growth medium and a 100 ± 1% increase for clones grown under Cu(II) stress. With CusB_M241I and CusB_M227I, there were increases of 30 ± 3 and 23 ± 4%, respectively, in the dead cell count before incorporating Cu(II) into the growth medium and increases of 90 ± 2% and 75 ± 1%, respectively, for the same clones grown under Cu(II) stress.

Fig 5. Cell viability imaging.

Fig 5

A. Cell viability imaging for WT-CusB, CusB_M64I, and CusB_M241I; cells were grown with and without Cu(II) at the late lag phase (3–4 hr). Green dots denote live cells; red dots denote dead cells. B. Cell viability comparison at the late lag phase for all CusB clones in the presence and absence of Cu(II). C. Cell viability imaging for WT-CusB and M241I grown with Cu(II) as a function of time. Green dots denote live cells; red dots denote dead cells. D. Cell viability comparison for all CusB clones in the presence of Cu(II) as a function of time.

Monitoring the cell viability, as a function of time, revealed that changes in growth rates were followed by cell deaths and not merely slower cell growth (Fig 5C and 5D). After 8 hr of growth in 3 µM Cu(II), 60 ± 7% of cells containing WT-CusB remained alive and 18 ± 2% remained alive for CusB_M64I. The percentages of living cells after 8 hr of growth in 3 µM Cu(II) were 16 ± 2% and 20 ± 1% for CusB_M241I and CusB_M227I, respectively.

Discussion

The CusCBA efflux system plays an indispensable role in copper homeostasis and cell viability within E. coli cells, and CusB controls the opening of the whole CusCBA complex. Understanding how CusB functions at the molecular level could facilitate the design of an inhibitor for the whole CusCBA efflux system. The trigger for opening the channel was shown to be the interaction between the metallochaperone CusF and the N-terminal domain of CusB (CusB_NT) associated with Cu(I) binding [2527, 44]. Previously, we and others studied CusB_NT and elucidated the significance of the three conserved methionine residues (M49, M64, and M66) for Cu(I) binding within CusB_NT [21, 23, 26, 27]. In another study on full-length CusB, we found that CusB dimer had to adopt a specific conformation in association with Cu(I) binding [22]. Importantly, we showed that domains 2 and 3 underwent major structural changes associated with Cu(I) binding, in agreement with the crystal structure reported; this suggests that an additional Cu(I) site exists in this region. In the present study, we initially performed cell growth experiments. Each time, we mutated a different methionine residue. All mutants affected the cell growth rate. However, four of them had a slightly larger effect on the cell growth compared to the others, and therefore we focused on these mutants. By coupling in-vitro and cell experiments, we highlighted the importance of three methionine residues: M64 (N-terminal domain), M227 (domain 3), and M241 (domain 2) for the growth rate and viability of the E. coli cells, and for the proper conformational changes in CusB. Pulsed EPR spectroscopy (DEER) showed that when one of the three methionine residues was replaced, it affected the conformational changes of CusB in the presence of Cu(I). Evaluating the KD value using UV-vis spectroscopy has shown that CusB binds Cu(I) ions with diminished affinity when it lacks one of the Met residues. Live/dead fluorescence cell imaging assisted in confirming that a mutation in one of the CusB methionine residues largely affects the cell viability. Time-dependent live/dead cell fluorescence imaging confirmed that CusB mutations lead to cell death and not merely to decreased cell growth. This finding indicates that introducing mutations in CusB results in toxicity that eventually leads to cell death within 8 hr. Our experimental data clearly indicates that at least one Cu(I) binding site exists in domain 2 and 3 of CusB. However, further study is required in order to better resolve this issue. Combining cell experiments with in-vitro experiments provided us with a deeper insight into the mechanism underlying the efflux system and an enhanced understanding of why point mutations decrease cell viability.

Conclusions

By combining in-vitro structural measurements with cell experiments, we obtained better understanding of the mechanism of action underlying the adapter protein within the copper efflux system in Gram-negative bacteria, at the molecular and nanoscale levels. Our experiments in both solution and cells suggest that besides the essential methionine residues reported before, there are two additional methionine residues at CusB domains 2 and 3 (M227 and M241) that are important for proper function of the CusCBA transporter. Mutating these methionine residues affects the conformational changes of CusB in the presence of Cu(I) and reduces the functionality of the CusB protein, which decreases copper resistance and increases cell toxicity in pathogenic cells.

Materials and methods

Experimental details and control experiments are described in the Supporting Information.

Supporting information

S1 Fig. Western blot gel for WT-CusB, ΔCusB, and CusB various mutants indicating on identical expression levels.

(TIF)

S2 Fig. Cell growth experiment.

OD after 16 hr for recombinant CusB, endogenic CusB, ΔCusB and BL21 cells with empty PYTB12 plasmid.

(TIF)

S3 Fig

Cell growth rates for various CusB clones in the absence (A) and presence (B), respectively, of 3 μM Cu(II).

(TIF)

S4 Fig

A. OD after 16 hr for native E. coli cells as affected by Cu(I) concentration. B. OD after 16 hr for ΔCusB cells affected by Cu(I) concentration. For ΔCusB cells, cell growth was terminated at a lower Cu(II) concentration. C. OD after 16 hr for ΔCusB-mutant cells as affected by Cu(I) concentration.

(TIF)

S5 Fig. Effects of rich medium (LB broth) on cell growth.

A. OD after 16 hr for native E. coli cells grown in LB medium. B. OD after 16 hr for ΔCusB cells grown in LB medium as affected by 3mM Cu(II). C. OD after 16 hr for ΔCusB cells grown in LB medium as affected by 3mM Cu(I).

(TIF)

S6 Fig

A. Spin-label positions and orientations attached to CusB_A236C_A248C in apo and holo states. B. The distance distribution obtained and shown in Fig 3B. The red dotted lines corresponds to the linear composition a*f(r)+(1-a)*g(r); where f(r) is apo CusB distance distribution and g(r) is CusB+Cu(I) distance distribution.

(TIF)

S1 File. Materials and methods.

(PDF)

Acknowledgments

SR acknowledges the support of ISF grant no. 176/16.

Abbreviations

CusCBA

Heavy metal efflux complex

CueO

Copper oxidize

CopA

Copper transporter

CueR

Copper efflux regulator

CusB_NT

CusB N-terminal domain

UV-Vis

Ultraviolet Visible spectroscopy

EPR

Electron paramagnetic resonance

DEER

Double electron electron resonance

SDSL

Site directed spin labeling

PDB

Protein data bank

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

SR acknowledges the support of ISF grant no. 176/16.

References

  • 1.Burkhead JL, Gogolin Reynolds KA, Abdel-Ghany SE, Cohu CM, Pilon M. Copper Homeostasis. New Phytologist. 2009;182:799–816. 10.1111/j.1469-8137.2009.02846.x [DOI] [PubMed] [Google Scholar]
  • 2.Pertersen C, Moller LB. Control of copper homeostasis escherichia coli by a P-type ATPase, CopA, and a Mer-like transcriptional activator, CopR. Gene. 2000;261:289–98. 10.1016/s0378-1119(00)00509-6 [DOI] [PubMed] [Google Scholar]
  • 3.Donnelly PS, Xiao ZG, Wedd AG. Copper and Alzheimer's disease. Curr Opin Chem Biol. 2007;11(2):128–33. 10.1016/j.cbpa.2007.01.678 [DOI] [PubMed] [Google Scholar]
  • 4.Syme CD, Nadal RC, Rigby SEJ, Viles JH. Copper binding to the amyloid-beta (A beta) peptide associated with Alzheimer's disease—Folding, coordination geometry, pH dependence, stoichiometry, and affinity of A beta-(1–28): Insights from a range of complementary spectroscopic techniques. J. Biol. Chem. 2004;279(18):18169–77. 10.1074/jbc.M313572200 [DOI] [PubMed] [Google Scholar]
  • 5.Tokuda E, Okawa E, Watanabe S, Ono S-i. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1. Human Mol Gen. 2014;23:1271–85. [DOI] [PubMed] [Google Scholar]
  • 6.Dollowet HHA, Sorenson JRJ. Historic uses of copper compounds in medicine. Trace elements in medicine. 1985;2:80–7. [Google Scholar]
  • 7.Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis and neurodegenerative disorder (Alzheimer's, Prion, and Parkinson's Diseases and Amyotropic Lateral Sclerosis). Chem Rev. 2009;106:1995–2044. [DOI] [PubMed] [Google Scholar]
  • 8.Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol. 2010;14:211–7. 10.1016/j.cbpa.2010.01.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rensing C, Grass G. Escherichia coli mechanisms of copper homeostasis in a changing environemnt. FEMS Microbiol Rev. 2003;27:197–213. 10.1016/S0168-6445(03)00049-4 [DOI] [PubMed] [Google Scholar]
  • 10.Fu Y, Chang F-M, J., Giedroc DP. Copper transport and trafficking at the host-bacterial pathogen interface. Acc Chem Res. 2014;47:3605–13. 10.1021/ar500300n [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Changela A, Chen K, Holschen J, Outten CE, O'Halloran TV, Mondragon A. Molecular basis of metal-ion selectivity and zeptomolar sensitivity by CueR. Science. 2003;301:1383–7. 10.1126/science.1085950 [DOI] [PubMed] [Google Scholar]
  • 12.Rensing C, Fan B, Sharma R, Mitra B, Rosen BP. CopA: An Escherichia coli Cu(I) translocating P-type ATPase. Proc. Nat. Acad. Sci. 2000;97:652–6. 10.1073/pnas.97.2.652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Franke S, Grass G, Rensing C, Nies DH. Molecular analysis of the copper-transporting efflux system CusCFBA of Escherchia coli. J Bacteriol. 2003;185(113):3804–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Grass G, Rensing C. CueO is a multi-copper oxidase that confers copper tolerance in escherichia coli. BioChem BioPhys Res Commun. 2001;286:902–8. 10.1006/bbrc.2001.5474 [DOI] [PubMed] [Google Scholar]
  • 15.Outten FW, Outten CE, Hale JA, O'Halloran TV. Transcriptional activation of an Escherichia coli copper efflux regulon by the chromosomal Mer homologue, CueR. J. Biol. Chem. 2000;275:31024–9. 10.1074/jbc.M006508200 [DOI] [PubMed] [Google Scholar]
  • 16.Janganan TK, Bavro VN, Zhang L, Matak-Vinkovic D, Barrera NP, Venien-Bryan C, et al. Evidence for the assembly of a bacterial tripartite mutidrug pump with a stoichometry of 3:6:3. J. Biol. Chem. 2011;286:26900–12. 10.1074/jbc.M111.246595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Su C-C, Long F, Zimmermann MT, Rajashankar KR, Jernigan RL, E.W. Y. Crystal Structure of the CusBA heavy-metal efflux complex of Escherichia coli. Nature. 2011;470:558–63. 10.1038/nature09743 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Su C-C, Yang F, Long F, Reyon D, Routh MD, Kuo DW, et al. Crystal structure of the membrane fusion protein CusB from Escherichia coli. J. Mol. Biol. 2009;393:342–55. 10.1016/j.jmb.2009.08.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lei H-T, Bolla JR, Bishop NR, Su C-C, Yu EW. Crystal structures of CusC review conformational changes accompanying folding and transmembrane channel formation. J. Mol. Biol. 2014;426:403–11. 10.1016/j.jmb.2013.09.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Padilla-Benavides T, George AM, McEvoy MM, Arguello JM. Mechanism of ATPase-mediated Cu+ export and delivery to periplasmic chaperones: the interaction of Escherichia coli CopA and CusF. J. Biol. Chem. 2014;289:20492–501. 10.1074/jbc.M114.577668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chacón KN, Mealman TD, McEvoy MM, Blackburn ME. Tracking metal ions through a Cu/Ag efflux pump assigns the functional roles of the periplasmic proteins. Proc. Nat. Acad. Sci. 2014;111:15373–8. 10.1073/pnas.1411475111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Meir A, Abdelhai A, Moskovitz Y, Ruthstein S. EPR spectroscopy targets conformational and topological changes in the E.coli membrane fusion CusB dimer upon Cu(I) binding. Biophys J. 2017;112:2494–502. 10.1016/j.bpj.2017.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bagai I, Liu W, Rensing C, Blackburn NJ, McEvoy MM. Substrate-linked conformational change in the periplasmic component of a Cu(I)/Ag(I) efflux system. J. Biol. Chem. 2007;282(49):35695–702. 10.1074/jbc.M703937200 [DOI] [PubMed] [Google Scholar]
  • 24.Santiago AG, Chen T-Y, Genova LA, Jung W, Thompson AMG, McEvoy MM, et al. Adaptor protein mediates dynamic pump assembly for bacterial metal efflux. Proc. Nat. Acad. Sci USA. 2017;114:6694–9. 10.1073/pnas.1704729114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mealman TD, Bagai I, Singh P, Goodlett DR, Rensing C, Zhou H, et al. Interactions between CusF and CusB identified by NMR spectroscopy and chemical cross-linking coupled to mass spectrometry. Biochem. 2011;50:2559–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mealman TD, Zhou M, Affandi T, Chacón KN, Aranguren ME, Blackburn NJ, et al. N-Terminal Region of CusB is sufficient for metal binding and metal transfer with the metallochaperone CusF. Biochem. 2012;51:6767–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Meir A, Natan A, Moskovitz Y, Ruthstein S. EPR spectroscopy identifies Met and Lys rediues that are essential for the interaction between CusB N-terminal domain and the metallochaperone CusF. Metallomics. 2015;7:1163–72. 10.1039/c5mt00053j [DOI] [PubMed] [Google Scholar]
  • 28.Ucisik MN, Chakravorty DK, Merz JKM. Structure and dynamics of the N-terminal domain of the Cu(I) binding protein CusB. Biochem. 2013;52:6911–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aitha M, Moritz L, Sahu ID, Sanyurah O, Roche Z, McCarrick RM, et al. Conformational dynamics of metallo-b-lactamase CcrA during catalysis investigated by using DEER spectroscopy. J. Biol. Inorg. Chem. 2015;20:585–94. 10.1007/s00775-015-1244-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Jeschke G. DEER Distance measurements on proteins. Annu Rev Phys Chem. 2012;63:419–46. 10.1146/annurev-physchem-032511-143716 [DOI] [PubMed] [Google Scholar]
  • 31.Joseph B, Morkhov VM, Yulikov M, Jeschke G, Bordignon E. Conformational cycle of the vitamin B12ABC importer in liposomes detected by Double Electron-Electron Resonance (DEER). J. Biol. Chem. 2014;289:3176–85. 10.1074/jbc.M113.512178 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Sahu ID, McCarrick RM, Troxel KR, Zhang R, Smith HJ, Dunagan MM, et al. DEER EPR measurements for membrane protein structures via bifunctional spin labels for lipodisp nanoparticles. Biochem. 2013;52:6627–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Klare JP. Site-directed spin labeling EPR spectroscopy in protein research. Biol Chem. 2013;394:1281–300. 10.1515/hsz-2013-0155 [DOI] [PubMed] [Google Scholar]
  • 34.Freed DM, Lukasik SM, Sikora A, Mokad A, Cafiso DS. Monomeric TonB and the Ton Box are required for the formation of a high affinity transporter-TonB complex. Biochem. 2013;52:2638–48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bhatnagar J, Sircar R, Borbat PP, Freed JH, Crane BR. Self-association of the histidine kinase CheA as studied by pulsed dipolar ESR spectroscopy. Biophys. J. 2012;102:2192–201. 10.1016/j.bpj.2012.03.038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Cafiso DS. Identifying and quantitating conformational exchange in membrane proteins using site-directed spin labeling. Acc. Chem. Res. 2015;47:3102–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hubbell WL, Gross A, Langen R, Lietzow MA. Recent advances in site-directed spin labeling of proteins. Curr. Opin. Struct. Biol. 1998;8:649–56. [DOI] [PubMed] [Google Scholar]
  • 38.Hubbell WL, Lopez CJ, Altenbach C, Yang Z. Technological advances in site-directed spin labeling of proteins. Curr. Opin. Chem. Biol. 2013;23:725–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Jeschke G. MMM: A toolbox for integrative structure modeling. Prot Sci. 2018;27:76–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kahra D, Kovermann M, Wittung-Stafshede P. The C-Terminus of Human Copper Importer Ctr1 Acts as a Binding Site and Transfers Copper to Atox1. Biophys. J. 2016;110(1):95–102. 10.1016/j.bpj.2015.11.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Young TR, Wedd AG, Xiao Z. Evaluation of Cu(i) binding to the E2 domain of the amyloid precursor protein—a lesson in quantification of metal binding to proteins via ligand competition. Metallomics. 2018;10(1):108–19. 10.1039/c7mt00291b [DOI] [PubMed] [Google Scholar]
  • 42.Xiao Z, Wedd AG. The challenges of determining metal-protein affinities. Nat. Prod. Rep. 2010;27:768–89. 10.1039/b906690j [DOI] [PubMed] [Google Scholar]
  • 43.Xiao Z, Brose J, Schimo S, Ackland SM, La Fontaine S, Wedd AG. Unification of the copper(I) binding affinities of the metallo-chaperones Atx1, Atox1, and related proteins: detection probes and affinity standards. J. Biol. Chem. 2011;286(13):11047–55. 10.1074/jbc.M110.213074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Melek N, Ucisik MN, Chakravorty DK, Merz JKM. Models for the metal tarnsfer complex of the N-terminal region of CusB and CusF. Biochem. 2015;54:4226–35. [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Dariush Hinderberger

7 Aug 2019

PONE-D-19-17365

Exploring the role of the various methionine residues in the Escherichia coli CusB adapter protein

PLOS ONE

Dear Prof. Ruthstein, dear Sharon

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

As you will see, the three expert reviewers in general deemed your study very interesting and worthy of publication. Especially reviewer 2 raised some issues concerning the data interpretation that I would ask you to take into account in particular.

We would appreciate receiving your revised manuscript by Sep 21 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Dariush Hinderberger

Academic Editor

PLOS ONE

Journal Requirements:

1.    When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Developing novel drugs to eliminate new pathogenic bacteria is one of the highest priority in antibiotics research. One of the best approaches is to inhibit copper transporters in prokaryotic systems which is required for many crucial biological pathways. Pathogenic systems contain a highly sophisticated copper-regulation network. Recently, it was revealed that the CusB protein part of the CusCBA periplasmic Cu(I) efflux system in Gram-negative bacteria, play an important key role in the functioning of the whole CusCBA system

In this manuscript, the authors targeted two methionine residues (M227 and M241) that are essential for the proper function of CusB of Escherrichia coli. The authors used a combination of in-vitro spectroscopic measurements and cell experiments to study the significance of each single methionine residue in CusB and its effect on cell survival. Indeed, they used pulsed EPR spectroscopy to study the conformational changes of CusB associated with Cu(I) binding.

The combination of the in-vitro structural measurements comprised of double electron-electron resonance (DEER) spectroscopy, coupled with site directed spin labeling (SDSL). Also, the DEER technique pulsed electron double resonance (PELDOR) was used to measure the dipolar interactions between two or more electron spins. The authors compared the DEER data with the structure of CusB and used multiscale modeling of macromolecular systems.

Moreover, the authors evaluated the binding affinity of CusB proteins for Cu(I) by using the spectrophotometric competition assay with bicinchoninic acid (BCA) as a ligand. Furthermore, the authors conducted live/dead fluorescence cell imaging experiments to determine whether point mutations might lead to cell death or only to a reduction in E. coli cell growth.

In this excellent rationale, they showed that beside essential methionine residues reported before, there were two additional methionine residues at CusB domains 2 and 3 (M227 and M241) that are important for proper function of the CusCBA transporter. Mutating these methionine residues inhibits conformational changes in CusB in the presence of Cu(I) and results in a non-functional CusB protein, decreased copper resistance, and increased cell toxicity in pathogenic cells.

This manuscript is very well written and it was a pleasure reading it. The biochemical analytical work and associated single-point mutation genetics is outstanding.

Tow minor comments are indicated:

1. There are lots of scientific abbreviation like: multicopper oxidase CueO, CopA, CusCBA that should be defined for the non- biochemistry expert.

2. In page ,lines 71 and 72 you have written the following;

The inner and the outer membrane proteins are connected by a linker protein, CusB, in the periplasm, and are at a CusA: CusB: CusC oligomerization ratio of 3:6:3 [16].

QUERY: Do you mean that the inner and the outer membrane proteins are connected by a linker protein, CusB, in the periplasm, which is composed of a CusA: CusB: CusC oligomerization ratio of 3:6:3 [16].

If that’s what you mean, than my correction seems better

Reviewer #2: The study by Meir et al. described in this manuscript focuses on the effects of Cu(I) binding to CusB, being part of the periplasmic CusCBA copper-I efflux system of (pathogenic) gram-negative bacteria. The authors combined structural investigations using EPR (DEER) spectroscopy, photometric Cu(I)-binding assays and live cell experiments to obtain insights into the functional relevance of several methionine residues in CusB.

The subject of this study is of high relevance for the field of antibiotics research, opening pathways to new antibiotics specifically targeting the Cus system of pathogenic bacteria that is not present in mammalian cells.

The concept of this study is well elaborated, the experiments appear to be performed expertly from a technical point of view, and the results obtained in this study reveal valuable insights into the function of the CusB protein, esp. its Cu(I) binding properties.

Nevertheless, interpretation of the data and its representation in the form of the present manuscript do not appear appropriate for publication without major revisions as detailed in the following.

1. Major points to address:

- The authors state that expression levels (Fig. S5) and secondary structure (Fig. S4, stated in l. 127/8 and l. 156) of all mutant clones are identical. Apart from the fact that this is only shown for 4 of the 10 mutants prepared, the CD spectra depicted in Fig. S4 do show clear differences between wt and the mutants. These differences are obvious and if it is stated that the secondary structure is not affected by the met mutations, this should be clearly shown by quantitative analyses of the CD spectra in terms of secondary structure content.

- Analysis and interpretation of the DEER data needs to be elaborated in more detail. The statement "..., whereas in the holo-state the spin labels are found in a symmetrical orientation, which results in a much narrower distance distribution" is not clear. What do you mean by "symmetrical orientation" of the labels and what does that mean for the overall structure of the protein (dimer).

I also do not see, that the structural changes are "inhibited" in the mutants 227, 241 and 64 to various extents, as I cannot clearly identify a simple shift in an equilibrium between two populations in the distance distributions. Especially when comparing the distance distributions for CusB_M241I, M227I and M64I with holo- and apo-CusB, it appears that the structural alterations upon Cu(I) binding are more complex for the mutants than a simple two-state equilibrium.

Another minor point concerning the comparison with the RLA results: It has been shown that the RLA for MTSSL calculated at 298 K performs better than the one for 175 K.

- Refering to the structural models shown in Fig. 6 with the positions of M227 and M241, the authors predict two Cu(I) binding sites in the CusB dimer comprised by these residues, respectively. Nevertheless, as stated in the text, these residues exhibit Calpha-Calpha distances > 2 nm, making it very unlikely that e.g. the two M241 residues in the dimer (2.05 nm in the holostate) can together coordinate one Cu(I) ion. Thus I do not see any indications for such Cu binding site based on the results shown here.

Also, the prediction for another binding site comprised by M227 residues from interacting dimers in the CusCBA complex is not supported by any structural model or experimental data obtained with the assembled complex. The major question concerning this predicted binding site, that is if the CusB dimers could assemble in an appropriate orientation for bringing two M227 residues in close proximity, could be addressed for example with docking approaches.

- In the discussion section the authors state that mutation of M227 or M241 lead to "nonfunctional" CusB, what is simply not true. Both mutants still bind Cu(I) (cf. Table 1), and the affinities are only reduced ~2-fold. Thus I would describe it as reduced or impaired functionality, what is also reflected in the clear but not dramatically decreased growth rates observed in the cell experiments.

- English writing is poor in some parts of the manuscript, often leading to sentences that are difficult to understand (see below for the most relevant examples). I recommend to let a native speaker revise the manuscript.

2. Formal (textual) points to address:

- Fig. 1: the domain structure of CusB should be indicated (e.g. by different colors for the 4 domains) in the structure in panel B. It would also be very helpful to indicate the positions of the Met residues (esp. of the four mutants addressed in detail in this manuscript) in this figure. The same for Fig. 3C.

- Fig. 2: Panels A and B are "horrible". Esp. in panel A one cannot identify the single growth curves. I would suggest to show only the growth curves of the four "relevant" mutants in this figure and shift the other curves to the SI. Furthermore, in the main text only the final OD's after 14 h of growth are discussed (panel C) and not the growth kinetics. Thus, Fig. 2 could be reduced to show only panel C and all growth curves could be placed in the SI. Alternatively, the growth kinetics need to be (at least briefly) described in the text.

- l. 70/71: I guess you mean "...and an outer membrane protein (CusC)".

- l. 125: "..., we introduced a single point mutation in one of them." - not clear, please reformulate

- l. 136/7: " ...under Cu(II) was reduced by..., compared with wild-type (WT) CusB after 14 h..." - I guess you mean that the growth rate of the WT was reduced under Cu(II) stress compared to Cu-free growth conditions.

- l. 181: I do not understand what you mean with "...the distance distribution between four spin labels was consumed"!

- ll. 183-190: The description of the rotamer library approach implemented in MMM and used here is not well described. First, the authors did not perform multiscale modeling, they only used the RLA apprach implemented in the software. Second, MMM is not a computational approach that was used to derive the rotamer library. The RLA is only implemented in MMM.

- l. 248: An increased kD value does not weaken the binding, the weaker binding is reflected by the increased kD.

- l. 274: What is "An identical imaging comparison..." ?

- l. 305/6: I do not understand what "...it indicates that within 8 hr of selective CusB Met residue inhibition" means.

- l. 311: omit "numerically"

- SI, tables S1, S2, S3: Please reduce the number of decimal digits (Max. 1-2) for columns [Cu(I)-BCA2] and [Cu(I)-protein].

Reviewer #3: This study seeks to extend the understanding of the role of the various methionine residues present in copper efflux system (CusCBA). In addition to the important residues identified in previous studies the authors have identified two additional residues of importance for the function of the CusB protein. In particular, mutations of these residues led the authors to identifying an important inhibition of a conformational change upon Cu binding.

This is a very nice multi-technique study that uses a combination of cell growth studies, DEER (to probe conformational changes), and spectrophotometric assays to determine Cu(I) binding. The entire package presents a very convincing argument and strongly suggests further study as to the detailed role of the residues identified. I have some minor comments below but the manuscript is fit for publication.

Comments

Cell growth studies

I do not feel especially qualified to comment on the cell growth studies, however they appear to be well done and support the conclusions drawn in the paper.

I have one question in re: to the comment: “…slight effect caused by the minimal copper concentration naturally present…and the significance of the methionine residues…” Is it known how much copper is present in the growth medium?

DEER studies

This is an ideal use of DEER, and is well done. Some comments:

Line 181: “…the distance distribution was consumed…” I am not sure what this sentence is saying. Do the authors mean conserved?

Figure 3B caption: missing space after “…CusB+Cu(I)”. Should read “…+Cu(I) structure models.”

Cu(I) affinity studies by UV-Vis

Some concerns with the data:

Figure 4A: While the peak height is decreasing there appears to be a baseline shift as well. Figure 4B shows clean isobestic points, but these appear absent in 4A. Could the authors comment about this? The derived Kd values appear reasonable, however.

Cell viability studies

Similar to above, I am not qualified to comment in a significant way, but these appear to be well done and support the overall conclusions.

Would it be possible to merge these studies with the cell growth studies? May shorten the manuscript in a useful way. They seem highly related (though this very well may just be my lack of experience with these types of microbiological studies).

General comments

This is a well-written and concise manuscript that forms a convincing argument as to the newly identified importance of the two residues of interest. The data is high quality and a significant amount of important supplemental data has been included.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Joseph Banoub

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: jb PLOS ONE REF.docx

PLoS One. 2019 Aug 29;14(8):e0219337. doi: 10.1371/journal.pone.0219337.r002

Author response to Decision Letter 0


12 Aug 2019

Reviewer #1: Developing novel drugs to eliminate new pathogenic bacteria is one of the highest priority in antibiotics research. One of the best approaches is to inhibit copper transporters in prokaryotic systems which is required for many crucial biological pathways. Pathogenic systems contain a highly sophisticated copper-regulation network. Recently, it was revealed that the CusB protein part of the CusCBA periplasmic Cu(I) efflux system in Gram-negative bacteria, play an important key role in the functioning of the whole CusCBA system

In this manuscript, the authors targeted two methionine residues (M227 and M241) that are essential for the proper function of CusB of Escherrichia coli. The authors used a combination of in-vitro spectroscopic measurements and cell experiments to study the significance of each single methionine residue in CusB and its effect on cell survival. Indeed, they used pulsed EPR spectroscopy to study the conformational changes of CusB associated with Cu(I) binding.

The combination of the in-vitro structural measurements comprised of double electron-electron resonance (DEER) spectroscopy, coupled with site directed spin labeling (SDSL). Also, the DEER technique pulsed electron double resonance (PELDOR) was used to measure the dipolar interactions between two or more electron spins. The authors compared the DEER data with the structure of CusB and used multiscale modeling of macromolecular systems.

Moreover, the authors evaluated the binding affinity of CusB proteins for Cu(I) by using the spectrophotometric competition assay with bicinchoninic acid (BCA) as a ligand. Furthermore, the authors conducted live/dead fluorescence cell imaging experiments to determine whether point mutations might lead to cell death or only to a reduction in E. coli cell growth.

In this excellent rationale, they showed that beside essential methionine residues reported before, there were two additional methionine residues at CusB domains 2 and 3 (M227 and M241) that are important for proper function of the CusCBA transporter. Mutating these methionine residues inhibits conformational changes in CusB in the presence of Cu(I) and results in a non-functional CusB protein, decreased copper resistance, and increased cell toxicity in pathogenic cells.

This manuscript is very well written and it was a pleasure reading it. The biochemical analytical work and associated single-point mutation genetics is outstanding.

Author’s reply: thank you very much.

Two minor comments are indicated:

1. There are lots of scientific abbreviation like: multicopper oxidase CueO, CopA, CusCBA that should be defined for the non- biochemistry expert.

Author’s reply: Abbreviation table was added to the manuscript

2. In page ,lines 71 and 72 you have written the following;

The inner and the outer membrane proteins are connected by a linker protein, CusB, in the periplasm, and are at a CusA: CusB: CusC oligomerization ratio of 3:6:3 [16].

QUERY: Do you mean that the inner and the outer membrane proteins are connected by a linker protein, CusB, in the periplasm, which is composed of a CusA: CusB: CusC oligomerization ratio of 3:6:3 [16].

If that’s what you mean, than my correction seems better

Author’s reply: thanks - we corrected the sentence according to your suggestion.

Reviewer #2: The study by Meir et al. described in this manuscript focuses on the effects of Cu(I) binding to CusB, being part of the periplasmic CusCBA copper-I efflux system of (pathogenic) gram-negative bacteria. The authors combined structural investigations using EPR (DEER) spectroscopy, photometric Cu(I)-binding assays and live cell experiments to obtain insights into the functional relevance of several methionine residues in CusB.

The subject of this study is of high relevance for the field of antibiotics research, opening pathways to new antibiotics specifically targeting the Cus system of pathogenic bacteria that is not present in mammalian cells.

The concept of this study is well elaborated, the experiments appear to be performed expertly from a technical point of view, and the results obtained in this study reveal valuable insights into the function of the CusB protein, esp. its Cu(I) binding properties.

Nevertheless, interpretation of the data and its representation in the form of the present manuscript do not appear appropriate for publication without major revisions as detailed in the following.

Author’s reply: Thank you for your comments – they are very helpful, we addressed them below based on your suggestions.

1. Major points to address:

- The authors state that expression levels (Fig. S5) and secondary structure (Fig. S4, stated in l. 127/8 and l. 156) of all mutant clones are identical. Apart from the fact that this is only shown for 4 of the 10 mutants prepared, the CD spectra depicted in Fig. S4 do show clear differences between wt and the mutants. These differences are obvious and if it is stated that the secondary structure is not affected by the met mutations, this should be clearly shown by quantitative analyses of the CD spectra in terms of secondary structure content.

Author’s reply: The quantitative analysis of the CD spectra was added to the SI (Figure S5). Ten mutations were prepared for the cell experiments, in vitro experiments were performed on four mutations, and therefore for the CD we used them. The CD suggests less than 3% effect on the secondary structure. We revised the conclusion in the SI, and deleted the above statement from the text.

- Analysis and interpretation of the DEER data needs to be elaborated in more detail. The statement "..., whereas in the holo-state the spin labels are found in a symmetrical orientation, which results in a much narrower distance distribution" is not clear. What do you mean by "symmetrical orientation" of the labels and what does that mean for the overall structure of the protein (dimer).

I also do not see, that the structural changes are "inhibited" in the mutants 227, 241 and 64 to various extents, as I cannot clearly identify a simple shift in an equilibrium between two populations in the distance distributions. Especially when comparing the distance distributions for CusB_M241I, M227I and M64I with holo- and apo-CusB, it appears that the structural alterations upon Cu(I) binding are more complex for the mutants than a simple two-state equilibrium.

Another minor point concerning the comparison with the RLA results: It has been shown that the RLA for MTSSL calculated at 298 K performs better than the one for 175 K.

Author’s reply: We rewrote the DEER section, Figure S2 was added to the SI, and we hope that with these changes it is more clear. The DEER section was written as follow: “To compare the DEER data with the structure of CusB, we used the MMM software (2015 version) [39]. The software requires an entry PDB file, and the residues where the spin-labels are attached to the protein. This method describes spin labels by a set of alternative conformations or rotamers, which can be attached without serious clashes with atoms of other residues or cofactors. The rotamer library is derived from molecular dynamic simulation with a total length of 100 ns at a temperature of 175K, which is an estimate of the glass transition of a protein sample. Here we used the two structures of apo-CusB and holo-CusB, which were previously constructed based on various DEER constraints (Figure 1B) as an input PDB files for the MMM software [22]. The dashed black-line distribution in Figure 3B denotes the distance distribution obtained from MMM. The apo-state exhibits a broad distance distribution that is consistent with the calculated model structure of CusB, whereas in the holo-state the structure is more compact and rigid, which results in a much narrower distance distribution [22]. The orientation of the spin-labels in the two structures are presented in Figure S2, SI. DEER also confirmed that when one specific methionine residue among M64, M227, and M241 was mutated, structural changes in CusB protein associated with Cu(I) binding were affected. For simplicity, we used a linear composition of the apo-WT-CusB distance distribution with the holo-WT-CusB distance distribution (see Figure S2, SI). Although the effect of each mutation on conformational changes may not be a simple two-step model between the apo- and holo-states, this approach can still provide us with an overview on how much each mutation disturbs the conformation and function of the CusB protein. In the case of CusB_M64I + Cu(I), the distance distribution is very similar to the apo WT-CusB distance distribution, suggesting that Cu(I) did not affect the conformation of CusB in the presence of M64I mutation. In contrast, for holo CusB_M398I, the distribution is slightly broader than the holo WT-CusB. However, the best fit was still obtained with 100% holo WT-CusB distance distribution, indicating that M398I did not affect the conformational changes of CusB upon Cu(I) binding. For CusB_M227I and CusB_M241I, the best fit was obtained with convolutions of 50% and 90%, respectively, of the apo-WT-CusB distance distribution with the holo-WT-CusB distance distribution. This suggests that both mutations affect the conformational changes of CusB in the presence of Cu(I), while M241I has a larger effect on conformation of CusB than the M227I mutation.”

We calculated the RLA both at 175K as well as 298K, there were no large differences. The 175K is a bit better fit for our data.

- Refering to the structural models shown in Fig. 6 with the positions of M227 and M241, the authors predict two Cu(I) binding sites in the CusB dimer comprised by these residues, respectively. Nevertheless, as stated in the text, these residues exhibit Calpha-Calpha distances > 2 nm, making it very unlikely that e.g. the two M241 residues in the dimer (2.05 nm in the holostate) can together coordinate one Cu(I) ion. Thus I do not see any indications for such Cu binding site based on the results shown here.

Also, the prediction for another binding site comprised by M227 residues from interacting dimers in the CusCBA complex is not supported by any structural model or experimental data obtained with the assembled complex. The major question concerning this predicted binding site, that is if the CusB dimers could assemble in an appropriate orientation for bringing two M227 residues in close proximity, could be addressed for example with docking approaches.

Author’s reply: We agree with the reviewer that based on the results presented in this manuscript, we cannot offer the structural model presented in Figure 6, therefore we deleted this part from the manuscript. However, we do think that the results clearly support the conclusion that M227 and M241 residues are important for proper function of CusB, which is the main conclusion of this study.

- In the discussion section the authors state that mutation of M227 or M241 lead to "nonfunctional" CusB, what is simply not true. Both mutants still bind Cu(I) (cf. Table 1), and the affinities are only reduced ~2-fold. Thus I would describe it as reduced or impaired functionality, what is also reflected in the clear but not dramatically decreased growth rates observed in the cell experiments.

Author’s reply: Yes we agree, and it was corrected in the text.

- English writing is poor in some parts of the manuscript, often leading to sentences that are difficult to understand (see below for the most relevant examples). I recommend to let a native speaker revise the manuscript.

Author’s reply: A native speaker checked and revised the manuscript

2. Formal (textual) points to address:

- Fig. 1: the domain structure of CusB should be indicated (e.g. by different colors for the 4 domains) in the structure in panel B. It would also be very helpful to indicate the positions of the Met residues (esp. of the four mutants addressed in detail in this manuscript) in this figure. The same for Fig. 3C.

Author’s reply: As suggested, we revised Figure 1, and added the domains to Figure 3C.

- Fig. 2: Panels A and B are "horrible". Esp. in panel A one cannot identify the single growth curves. I would suggest to show only the growth curves of the four "relevant" mutants in this figure and shift the other curves to the SI. Furthermore, in the main text only the final OD's after 14 h of growth are discussed (panel C) and not the growth kinetics. Thus, Fig. 2 could be reduced to show only panel C and all growth curves could be placed in the SI. Alternatively, the growth kinetics need to be (at least briefly) described in the text.

Author’s reply: We moved Figure 2A and 2B to the SI as suggested by the referee.

- l. 70/71: I guess you mean "...and an outer membrane protein (CusC)".

Author’s reply: Corrected.

- l. 125: "..., we introduced a single point mutation in one of them." - not clear, please reformulate

Author’s reply: We rephrased it: “Ten Met residues exist in CusB; in order to determine which of them are essential for cell growth, each time one methionine residue was mutated to isoleucine.”

- l. 136/7: " ...under Cu(II) was reduced by..., compared with wild-type (WT) CusB after 14 h..." - I guess you mean that the growth rate of the WT was reduced under Cu(II) stress compared to Cu-free growth conditions.

Author’s reply: yes, we corrected it.

- l. 181: I do not understand what you mean with "...the distance distribution between four spin labels was consumed"!

Author’s reply: The DEER section was rewritten – see the answer above.

- ll. 183-190: The description of the rotamer library approach implemented in MMM and used here is not well described. First, the authors did not perform multiscale modeling, they only used the RLA apprach implemented in the software. Second, MMM is not a computational approach that was used to derive the rotamer library. The RLA is only implemented in MMM.

Author’s reply: The DEER section was rewritten – see the answer above.

- l. 248: An increased kD value does not weaken the binding, the weaker binding is reflected by the increased kD.

Author’s reply: Corrected

- l. 274: What is "An identical imaging comparison..." ?

Author’s reply: thanks - we deleted it (it was out of context).

- l. 305/6: I do not understand what "...it indicates that within 8 hr of selective CusB Met residue inhibition" means.

Author’s reply: We rephrased it: “This finding indicates that introducing mutations in CusB results in toxicity that eventually leads to cell death within 8 hr.”

- l. 311: omit "numerically"

Author’s replay: Corrected.

- SI, tables S1, S2, S3: Please reduce the number of decimal digits (Max. 1-2) for columns [Cu(I)-BCA2] and [Cu(I)-protein].

Author’s reply: Was revised as suggested by the referee.

Reviewer #3: This study seeks to extend the understanding of the role of the various methionine residues present in copper efflux system (CusCBA). In addition to the important residues identified in previous studies the authors have identified two additional residues of importance for the function of the CusB protein. In particular, mutations of these residues led the authors to identifying an important inhibition of a conformational change upon Cu binding.

This is a very nice multi-technique study that uses a combination of cell growth studies, DEER (to probe conformational changes), and spectrophotometric assays to determine Cu(I) binding. The entire package presents a very convincing argument and strongly suggests further study as to the detailed role of the residues identified. I have some minor comments below but the manuscript is fit for publication.

Author’s reply: Thank you very much.

Comments

Cell growth studies

I do not feel especially qualified to comment on the cell growth studies, however they appear to be well done and support the conclusions drawn in the paper.

I have one question in re: to the comment: “…slight effect caused by the minimal copper concentration naturally present…and the significance of the methionine residues…” Is it known how much copper is present in the growth medium?

Author’s reply: Thanks - we added it to the text – it is 0.5 �M.

DEER studies

This is an ideal use of DEER, and is well done. Some comments:

Line 181: “…the distance distribution was consumed…” I am not sure what this sentence is saying. Do the authors mean conserved?

Author’s reply: We rephrased it in the text.

Figure 3B caption: missing space after “…CusB+Cu(I)”. Should read “…+Cu(I) structure models.”

Author’s reply: thanks – we corrected it.

Cu(I) affinity studies by UV-Vis

Some concerns with the data:

Figure 4A: While the peak height is decreasing there appears to be a baseline shift as well. Figure 4B shows clean isobestic points, but these appear absent in 4A. Could the authors comment about this? The derived Kd values appear reasonable, however.

Author’s reply: The spectra were baselined according to the absorption value at 800 nm, which is zero – we added it to the SI.

Cell viability studies

Similar to above, I am not qualified to comment in a significant way, but these appear to be well done and support the overall conclusions.

Would it be possible to merge these studies with the cell growth studies? May shorten the manuscript in a useful way. They seem highly related (though this very well may just be my lack of experience with these types of microbiological studies).

Author’s reply: The cell viability tests are complimentary to the cell growth experiments since they show that point mutations do not only affect cell growth but also are toxic to the cell. Therefore, we decided to leave this section to the end, since this is very important conclusion towards development of new antibiotics.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Dariush Hinderberger

16 Aug 2019

Exploring the role of the various methionine residues in the Escherichia coli CusB adapter protein

PONE-D-19-17365R1

Dear Dr. Ruthstein, dear Sharon,

I am pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Dariush Hinderberger

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Dariush Hinderberger

20 Aug 2019

PONE-D-19-17365R1

Exploring the role of the various methionine residues in the Escherichia coli CusB adapter protein

Dear Dr. Ruthstein:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Dr. Dariush Hinderberger

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Western blot gel for WT-CusB, ΔCusB, and CusB various mutants indicating on identical expression levels.

    (TIF)

    S2 Fig. Cell growth experiment.

    OD after 16 hr for recombinant CusB, endogenic CusB, ΔCusB and BL21 cells with empty PYTB12 plasmid.

    (TIF)

    S3 Fig

    Cell growth rates for various CusB clones in the absence (A) and presence (B), respectively, of 3 μM Cu(II).

    (TIF)

    S4 Fig

    A. OD after 16 hr for native E. coli cells as affected by Cu(I) concentration. B. OD after 16 hr for ΔCusB cells affected by Cu(I) concentration. For ΔCusB cells, cell growth was terminated at a lower Cu(II) concentration. C. OD after 16 hr for ΔCusB-mutant cells as affected by Cu(I) concentration.

    (TIF)

    S5 Fig. Effects of rich medium (LB broth) on cell growth.

    A. OD after 16 hr for native E. coli cells grown in LB medium. B. OD after 16 hr for ΔCusB cells grown in LB medium as affected by 3mM Cu(II). C. OD after 16 hr for ΔCusB cells grown in LB medium as affected by 3mM Cu(I).

    (TIF)

    S6 Fig

    A. Spin-label positions and orientations attached to CusB_A236C_A248C in apo and holo states. B. The distance distribution obtained and shown in Fig 3B. The red dotted lines corresponds to the linear composition a*f(r)+(1-a)*g(r); where f(r) is apo CusB distance distribution and g(r) is CusB+Cu(I) distance distribution.

    (TIF)

    S1 File. Materials and methods.

    (PDF)

    Attachment

    Submitted filename: jb PLOS ONE REF.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES